All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
ARKG real return snapshot: after CPI-U inflation, ARKG returned +53.32% over the past year and +42.99% YTD, with dividends reinvested. Since Oct. 31, 2014, ARKG is up +63.07% in real purchasing-power return, or +4.15%/yr, and is currently −70.13% below its real total-return high on Jan. 20, 2021.
Data ending Fri Nov. 13, 2026
| Fri 2014-10-31💬 to Fri 2026-11-13 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| ARKG × |
+63.07%
+4.15%/yr |
+1.79%/yr
R2=0.020 |
||||
| ARK Genomic Revolution ETF Exchange-Traded Fund | ||||||
| Fri 2014-10-31💬 to Fri 2026-11-13 |
Start
Value |
End
Value |
|---|---|---|
| ARKG × |
$10,000.00
2014-10-31 |
$16,307.45
2026-11-13 |
| YTD | YoY | |
|---|---|---|
| ARKG × | +42.99% | +53.32% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| ARKG × |
−70.13%
on 2026-11-13 from 2021-01-20 peak |
−86.61%
on 2025-04-08 from 2021-01-20 peak |
| Period ending Fri 2026-11-13 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| ARKG × | +53.32% |
+57.28% +25.41%/yr |
+64.77% +18.11%/yr |
−51.44% −13.45%/yr |
+77.50% +5.91%/yr |
| Year | ARKG |
|---|---|
| 2026 (YTD) | +42.99% |
| 2025 | +19.84% |
| 2024 | −30.25% |
| 2023 | +12.46% |
| 2022 | −56.70% |
| 2021 | −38.26% |
| 2020 | +176.63% |
| 2019 | +40.78% |
| 2018 | −1.99% |
| 2017 | +43.58% |
| 2016 | −20.90% |
| 2015 | −1.97% |
| 2014 | +6.80% |